Study of a novel three‐dimensional scaffold to repair bone defect in rabbit
- 7 May 2013
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 102 (5) , 1294-1304
Abstract
Both decalcified bone matrix (DBM) and fibrin gel possess good biocompatibility, so they are used as scaffolds to culture bone marrow mesenchymal stem cells (BMSCs). The feasibility and efficacy of using compound material being made of decalcified bone matrix and fibrin gel as a three-dimensional scaffold for bone growth were investigated. BMSCs were isolated from the femur of rabbit, then seeded in prepared scaffolds after incubation for 28 days in vitro. In vivo: 30 New Zealand White Rabbits received bone defect in left radius and divided three treatment groups randomly: (1) BMSCs/decalcified bone matrix/fibrin glue as experimental group; (2) decalcified bone matrix/fibrin glue without cells as control group; (3) nothing was implanted into the bone defects as blank group. The observation period of specimens was 12 weeks, and were analyzed bone formation in terms of serum proteomics (2D-PAGE and MALDI-TOF-TOF-MS), hematoxylin–eosin (HE) staining, ALP staining, and Osteopontin immunofluorescence detection. The experimental group present in three peculiar kinds of proteins, whose Geninfo identifier (GI) number were 136466, 126722803, and 126723746, respectively, correspond to TTR protein, ALB protein, RBP4 protein, and the histological inspections were superior to the other group. The content of osteopontin in experimental group was significantly higher than control group (p < 0.05). The overall results indicated that a combined material being made of BMSCs/decalcified bone matrix/fibrin glue can result in successful bone formation and decalcified bone matrix/fibrin glue admixtures can be used as a scaffold for bone tissue engineering. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1294–1304, 2014.Keywords
This publication has 31 references indexed in Scilit:
- Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2Biomaterials, 2007
- Evaluation of processed bovine cancellous bone matrix seeded with syngenic osteoblasts in a critical size calvarial defect rat modelJournal of Cellular and Molecular Medicine, 2006
- Fibrin as a cell carrier in cardiovascular tissue engineering applicationsBiomaterials, 2005
- Biocompatibility studies on fibrin glue cultured with bone marrow mesenchymal stem cellsin vitroCurrent Medical Science, 2004
- Skeletal tissue engineering—from in vitro studies to large animal modelsBiomaterials, 2004
- Quantitative and sensitive in vitro assay for osteoinductive activity of demineralized bone matrixJournal of Orthopaedic Research, 2003
- Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with beta-tricalcium phosphate as a carrier: in vivo bone banking for muscle-pedicle autograftJournal of Orthopaedic Science, 2002
- Use of Bone Morphogenetic Protein-2 in the Rabbit Ulnar Nonunion ModelClinical Orthopaedics and Related Research, 1996
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991
- Distribution of bone inductive proteins in mineralized and demineralized extracellular matrixBiochemical and Biophysical Research Communications, 1984